Business
MBX Biosciences Announces Additions to Leadership Team
Chatan Charan, Ph.D. appointed as Senior Vice President, Pharmaceutical Development and CMC Mark Hope appointed as Senior Vice President, Regulatory and
About this update from Mbx Biosciences, Inc.
[{"type":"text","content":"Chatan Charan, Ph.D. appointed as Senior Vice President, Pharmaceutical Development and CMC Mark Hope appointed as Senior Vice President, Regulatory and Quality CARMEL, Ind., March 05, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the appointments of Chatan Charan, Ph.D. as Senior Vice President, Pharmaceutical Development and Chemistry, Manufacturing and Controls (CMC) and Mark Hope as Senior Vice President, Regulatory and Quality. “We are excited to welcome Chatan and Mark, who will play a pivotal role in our next phase of growth as we seek to advance the development of transformative precision peptide therapeutics for patients in need,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. “Chatan and Mark add decades of leadership expertise in drug development and commercialization. We believe their combined experience and proven track record of successfully growing teams and organizations will be instrumental as we advance and expand our pipeline of novel product candidates.” Chatan Charan, Ph.D. said, “I am excited to join MBX and contribute to the advancement of its innovative peptide portfolio. I’ve been particularly impressed by the Company’s deep scientific foundation and high-potential early-stage candidates and am eager to collaborate with the talented MBX team to bring new therapies to patients in need.” Mark Hope said, “I am honored to lead MBX’s regulatory affairs and quality functions. Building a premier regulatory function with a high emphasis on innovation balanced with quality is essential to successfully deliver these precision peptides to patients. I look forward to working with the rest of the team to support our pipeline progress and deliver differentiated solutions to patients as quickly as possible.” Dr. Charan is an accomplished drug development leader, bringing over three decades of experience leading drug development over the entire lifecycle, manufacturing, clinical supply management, pharmacy and commercial technical services and technical operations. Prior to joining MBX, Dr. Charan served as Senior Vice President, Pharmaceutical Development, Technical and Manufacturing...